The sample is authorized to be self-collected in the presence of a healthcare professional, which reduces the risk to providers and increases scalability. The method doesn't require any special collection device, and almost any type of sterile swab can be used, he said. To collect the sample, a patient is instructed to cough three to five times and retain the product of the cough in their mouth, then swab the inside of the mouth, including under and on top of the tongue, the roof and sides of the mouth, and the upper and lower gums, for at least 20 seconds, Klausner explained. Jeffrey Klausner, acting medical director at the lab and a public health expert at the University of California, Los Angeles, explained in an interview that the oral fluid sample is a combination of upper respiratory tract fluid and saliva. The latter is notable, as it could circumvent swab supply shortages and sets the stage for the possibility of at-home self-collection. According to the EUA summary, it detects SARS-CoV-2 nucleic acids in oropharyngeal, nasopharyngeal, and nasal swabs, as well as oral fluid specimens. The partners, Curative and KorvaLabs, set up a designated COVID-19 lab in less than one month and have received Emergency Use Authorization from the US Food and Drug Administration for a lab-developed test.Ĭalled the Curative-Korva SARS-Cov-2 Assay, the test garnered EUA last week. NEW YORK – A partnership between an established infectious disease diagnostics team and a high-throughput laboratory with a pedigree in sports drug testing has led to a 10,000 per day increase in COVID-19 testing capacity in the Los Angeles area. Advances in Clinical Genomics Profiling.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |